Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Read Why Biogen Shares Are Trading Higher After Q1 Earnings

Biogen BIIB Biogen Inc Multiple Sclerosis Nasdaq
  • Biogen Inc (NASDAQ:BIIB) posted Q1 sales of 2.53 billion, beating the consensus of $2.49 billion, down 6% Y/Y.
  • Multiple sclerosis (MS) revenue, including royalties on sales of Ocrevus, of $1.79 billion decreased by 3%. 
  • Spinraza's revenue of $441 million decreased 9% at actual currency and 6% at constant currency. 
  • Aduhelm's revenue was $2.8 million.
  • Biosimilars' revenue of $194 million decreased 5% versus the prior year at actual currency and 1% at constant currency.
  • Sales of multiple sclerosis drug Tysabri rose nearly 3.5% to $520.8 million.
  • Adjusted EPS of $3.62 was down from 5.34 a year ago, missing the consensus of $4.38.
  • CEO Transition: Biogen has begun searching for a new Chief Executive Officer. Michel Vounatsos will continue to serve as CEO & board member until his successor is appointed.
  • Guidance: Biogen reaffirmed an FY22 adjusted profit of $14.25-$16.00 per share, compared to the consensus of $15.44.
  • The Company expects FY22 sales of $9.7 billion - $10.0 billion, compared to the consensus of $9.87 billion.
  • Price Action: BIIB shares are up 2.70% at $212.95 during the market session on the last check Tuesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Here's Why Moderna Shares Are Trading Higher After Q1 Earnings Today
Here's Why Moderna Shares Are Trading Higher After Q1 Earnings Today
Moderna Inc (NASDAQ:MRNA) reports a Q1 EPS of $8.58, compared to the $2.84 posted a year ago, handsomely beating the consensus estimate of $5.21. Total revenue was $6.1 billion compared to $1.9 billion in Q1 FY21, primarily due to increased product sales. The revenue consensus was $4.43 billion. Product sales were $5.9…
Benzinga
Benzinga
Why Lumentum Shares Are Trading Higher Today
Why Lumentum Shares Are Trading Higher Today
Lumentum Holdings Inc (NASDAQ:LITE) reported third-quarter FY22 revenue of $395.4 million, down 5.7% year-on-year, in line with the consensus. Optical Communications revenue declined 11.3% Y/Y to $344.2 million, and Lasers revenue rose 62% Y/Y to $51.2 million. Margins: The non-GAAP gross margin contracted 40 bps to 49.5%. The non-GAAP operating margin compressed 140 bps…
Benzinga
Benzinga
Why Kellogg Shares Are Trading Higher Today
Why Kellogg Shares Are Trading Higher Today
Kellogg Company (NYSE:K) reported first-quarter FY22 sales growth of 2.4% year-on-year to $3.67 billion, beating the consensus of $3.59 billion. Adjusted EPS of $1.10 beat the analyst consensus of $0.93. Kellogg North America's sales decreased 1%, Europe climbed 2%, Latin America's sales gained 8%, Asia Pacific, Middle East, and Africa's sales jumped 12%.…
Benzinga
Benzinga
Why Amarin Shares Are Plunging After Q1 Earnings
Amarin Corporation plc (NASDAQ: AMRN) shares are plunging after it said it would continue suspending 2022 revenue guidance and Q1 earnings came short of expectations.
Benzinga
Benzinga
From analysis to the latest developments in health, read the most diverse news in one place.
Already a member? Sign in here
Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook
Catalent Inc (NYSE:CTLT) reported Q3 FY22 sales of $1.27 billion, +21% Y/Y as reported, or 23% in constant currency, edging out analysts' average expectation of $1.22 billion. Adjusted EPS of $1.04, compared to $0.82 last year, surpassed the consensus of $0.94. Adjusted EBITDA was $339 million, or a margin of 27%, compared…
Benzinga
Benzinga
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise
Teva Pharmaceutical Industries Ltd's (NYSE:TEVA) Q1 sales reached $3.66 billion, shrinking 8% Y/Y, missing the consensus of $3.75 billion.  The decrease is mainly due to lower revenues from generic products in North America and Copaxone, partially offset by higher revenues from Anda and generic products in the Europe segment.  The adjusted gross…
Benzinga
Benzinga
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Is The Late Show with Stephen Colbert new tonight, March 27?
With CBS airing more March Madness games on March 27, The Late Show is being delayed. Here’s what you need to know about the tweaked schedule.
WhatToWatch
WhatToWatch
Hailey Bieber Dresses for Her Tax Bracket at Church, in a $4,450 Trench Coat
It's the ultimate rich-girl staple.
Marie Claire
Marie Claire
Projected WrestleMania 41 Card
Headlined by John Cena squaring off with Cody Rhodes for the undisputed WWE championship, the show features an immensely strong group of talent.
Sports Illustrated
Sports Illustrated
Marvel fans are already theorizing how Patrick Stewart, Ian McKellen, and James Marsden's X-Men will be integrated into Avengers: Doomsday
There are some pretty compelling theories about how the X-Men will appear in Avengers: Doomsday
Total Film
Total Film
Dave Grohl’s wife Jordyn Blum ‘makes decision about their future’ after his cheating scandal
Grohl revealed in September that he fathered a child outside of his marriage
The Independent UK
The Independent UK
“Poor Kid Is Scarred For Life”: Babysitter Checks For Monsters Under Kid’s Bed, Finds Man Hiding
The harrowing discovery was made after a child told the babysitter about a "monster" being in the same room with them. The post “Poor Kid Is Scarred For Life”: Babysitter Checks For Monsters Under Kid’s Bed, Finds Man Hiding first appeared on Bored Panda.
Bored Panda
Bored Panda
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play